Why are pathogenic SIV and HIV infections characterized by high level immune activation when other chronic virus infection are not? Lessons from nonpathogenic SIV infection in natu...

por Staprans, Silvija, Klucking, Sara, Silvestri, Guido, Chavan, Rahul, Barry, Ashley, Feinberg, Mark
Publicado 2006

An Aptamer for Broad Cancer Targeting and Therapy

por Powell Gray, Bethany, Song, Xirui, Hsu, David S., Kratschmer, Christina, Levy, Matthew, Barry, Ashley P., Sullenger, Bruce A.
Publicado 2020

Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci

por SoRelle, Elliott D., Reinoso-Vizcaino, Nicolás M., Dai, Joanne, Barry, Ashley P., Chan, Cliburn, Luftig, Micah A.
Publicado 2023

Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection

por Price, Alexander M, Dai, Joanne, Bazot, Quentin, Patel, Luv, Nikitin, Pavel A, Djavadian, Reza, Winter, Peter S, Salinas, Cristina A, Barry, Ashley Perkins, Wood, Kris C, Johannsen, Eric C, Letai, Anthony, Allday, Martin J, Luftig, Micah A
Publicado 2017

An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity

por Roche, Kathryn L., Remiszewski, Stacy, Todd, Matthew J., Kulp, John L., Tang, Liudi, Welsh, Alison V., Barry, Ashley P., De, Chandrav, Reiley, William W., Wahl, Angela, Garcia, J. Victor, Luftig, Micah A., Shenk, Thomas, Tonra, James R., Murphy, Eain A., Chiang, Lillian W.
Publicado 2023